Search results
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 5 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
GSK builds case for return of multiple myeloma drug Blenrep
BioPharma Dive via Yahoo Finance· 6 days agoStudy results showed the antibody-drug conjugate helped stave off disease progression better than a...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 5 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
The chicken and egg problem of fighting another flu pandemic
Arkansas Advocate via Yahoo News· 6 days agoThis article first appeared on KFF Health News and is reprinted here under a Creative Commons...
Scientists are testing vaccines to protect cows and people against bird flu
Temple Daily Telegram· 4 days agoThe bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA...
Improved Outcomes With Subcutaneous Amivantamab in NSCLC
Medscape· 6 days agoSubcutaneous amivantamab plus lazertinib may offer a survival benefit over intravenous administration, alongside dramatically reduced administration times, a new study suggests.
Moderna's RSV Vaccine Approved by FDA
Medscape· 5 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.
Co-Locating COVID Vaccines, Infection Testing With Syringe Services Shows Success
MedPage Today· 5 days ago...Among 347 participants across 10 co-located clinics participating in the Baltimore City Health...
Neoadjuvant Strategy Establishes Standard of Care for Resectable Stage III Melanoma
MedPage Today· 4 days agoCombination neoadjuvant immunotherapy for resectable melanoma reduced recurrence and other clinical...
ASCO: Cautious Big Pharmas double down on past wins—steering clear of radioligands and cell therapy
FierceBiotech· 3 days agoThis year’s American Society of Clinical Oncology (ASCO) conference in Chicago marked a return to...